Breathe Well Live Well
|
The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite …
MarketWatch BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain … |
View full post on asthma – Google News
|
PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
PharmaPoint: Asthma – US Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
PharmaPoint: Asthma – 5EU Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
Asthma – Epidemiology Forecast to 2023
PR Newswire (press release) Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term condition characterized by narrowing of the airways, leading to airflow limitation and airway hyper … |
View full post on asthma – Google News
|
Research and Markets: PharmaPoint: Asthma – 5EU Drug Forecast and Market …
Rock Hill Herald (press release) The relatively slow growth of the German market compared with the French, Spanish, and UK markets is attributable to the slightly decreasing prevalence of asthma in this country over the forecast period. Advair's active patent on the Diskus delivery … |
View full post on asthma – Google News
|
Lebrikizumab Asthma Market Analysis and Forecast to 2023
WhaTech Researcher has released its new PharmaPoint Drug Evaluation report, “Lebrikizumab (Asthma) – Forecast and Market Analysis to 2023?. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious … |
View full post on asthma – Google News
|
New Market Research Report: EpiCast Report: Asthma – Epidemiology Forecast …
SBWire (press release) Boston, MA — (SBWIRE) — 07/06/2013 — Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report … |
View full post on asthma – Google News
|
EpiCast Report: Asthma – Epidemiology Forecast to 2022
Sacramento Bee Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in … |
View full post on asthma – Google News
|
EpiCast Report: Asthma – Epidemiology Forecast to 2022
PR Newswire (press release) Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in … |
View full post on asthma – Google News